# Value of Prothrombin Fragment F1+2 in the Diagnosis of Pulmonary Embolism in Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbation

> **NCT01626521** · — · UNKNOWN · sponsor: **Hillel Yaffe Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease
- Pulmonary Embolism

## Interventions

- **OTHER:** CT pulmonary angio, blood tests

## Key facts

- **NCT ID:** NCT01626521
- **Lead sponsor:** Hillel Yaffe Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2012-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01626521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01626521, "Value of Prothrombin Fragment F1+2 in the Diagnosis of Pulmonary Embolism in Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01626521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*